MAPT and Alzheimer disease: Recently, our group demonstrated that the increase of EVs derived from myeloid cells (IB4+) measured in CSF of AD and mild cognitive impairment (MCI) patients correlates with classical biomarkers of neuronal injury (i.e., t-Tau, p-Tau, and Aβ1–42), demonstrating the diagnostic potential of EVs (18).